The UK’s proposed regulations would provide the legal framework for POC manufacturing of cell therapies, including quality assurance.

Sofgen, a supplier of softgel technologies for generics, prescription drugs, OTC products and specialised nutraceuticals, ...

Procaps Group, a leading integrated international healthcare and pharmaceutical company, today announced the closing of an asset purchase agreement to acquire an 86,000ft² pharmaceutical production ...

Health Canada certifies Sofgen Pharmaceuticals in Canadian Good Manufacturing Practices (GMP) for our compliance with the Food and Drug Regulations at its facilities. This new permit allows our ...

At Softigel by Procaps, we develop complex products encapsulated in softgel dosage forms and other delivery systems, high potency APIs, differentiated OTC products and nutritional supplements in novel ...

Johnson & Johnson Innovation Medicine has submitted a request to the FDA to approve Tremfya as a treatment for ulcerative ...

Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Health Canada has issued a Notice of Compliance (NOC) for Johnson & Johnson’s (J&J) CARVYKTI for multiple myeloma treatment.

TCR immunotherapy is emerging as a promising, targeted approach for treating solid tumours and other indications.

The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates ...

Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches ...

Zai Lab and Pfizer have entered a strategic collaboration for the commercialisation of XACDURO in mainland China.